Istanbul - Delayed Quote • TRY Alarko Gayrimenkul Yatirim Ortakligi A.S. (ALGYO.IS) Follow Compare 21.08 +0.04 +(0.19%) At close: January 30 at 6:09:38 PM GMT+3 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for ALGYO.IS 1D 5D -1.31% 1M -0.38% 3M 20.11% 6M -20.38% YTD 0.57% 1Y 3.59% 5Y 536.95% All 9,554.09% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller Atlassian (TEAM) Q2 2025 Earnings Call Transcript Apple Forecast Cheers Investors After Mixed Holiday Results Intel Fourth-Quarter Sales Beat Estimates During Turnaround Atlassian (TEAM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Apple Is Still Finding New Customers Apple iPhone Sales Shrink Slightly as Investors Await AI Payoff Compared to Estimates, Apple (AAPL) Q1 Earnings: A Look at Key Metrics Apple CEO says DeepSeek shows 'innovation that drives efficiency' Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain Apple Beats Earnings Target On Services Lift, But iPhone Sales Decline